DEAR DR. ROACH: I’m a 75-year-old woman who’s in very good health. Since my early 50s, I’ve had issues with my cholesterol. My doctor has put me on several statins that caused very sore joints and ...

Dear Dr. Roach: I’m a 75-year-old woman who’s in very good health. Since my early 50s, I’ve had issues with my cholesterol. My doctor has put me on several statins that caused very sore joints and ...

DEAR DR. ROACH: I’m a 75-year-old woman who’s in very good health. Since my early 50s, I’ve had issues with my cholesterol. My doctor has put me on several statins that caused very sore joints and ...

For the roughly 200 million people worldwide who take a statin every day, the routine is deceptively simple: swallow a pill, ...

Twice a year, a nurse slides a small needle under the skin of your upper arm. Thirty seconds later, you are done. No daily ...

Amgen CEO Robert Bradway has declared 2026 a “springboard year” for the California big biotech, in which the growth of its newer products will offset the loss of revenue from patent expirations and ...

Repatha (evolocumab) is a prescription medication used in certain situations to lower “bad” cholesterol and reduce serious heart-related risks. Here is a quick breakdown of how it works. Your liver ...

Repatha’s withdrawal from Denmark is best understood as an early signal of the impact of Most Favored Nation drug pricing proposals in the US. When low-price foreign markets become linked to large U.S ...

Recently published Acute Myocardial Infarction Market Insights report includes a comprehensive understanding of current treatment practices, acute myocardial infarction emerging drugs, market share of ...

The acute myocardial infarction market is experiencing steady growth driven by rising global cardiovascular disease prevalence and expanding geriatric populations. Advances in diagnostic technologies ...